Par Sterile Products LLC is recalling 1,721 cartons of Vasostrict (vasopressin in 5% Dextrose) Injection because the medication may be superpotent, meaning it contains more of the active ingredient than specified. Testing at the 3-month and 6-month stability intervals revealed that the drug exceeded its potency limits. No incidents or injuries have been reported to date, but the manufacturer is voluntarily recalling the affected batch to ensure patient safety.
A superpotent medication provides a higher dose than intended by the healthcare provider, which can lead to serious adverse clinical effects or toxicity. Because this drug is administered intravenously in critical care settings, receiving an incorrect dose poses a medium risk to patient health.
Recall #: D-0232-2024; Distributed by Par Pharmaceutical, Chestnut Ridge, NY 10977
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.